177 related articles for article (PubMed ID: 36619217)
1. Development of Tier 2 LC-MRM-MS protein quantification methods for liquid biopsies.
Diederiks N; Ravensbergen CJ; Treep M; van Wezel M; Kuruc M; Renee Ruhaak L; Tollenaar RAEM; Cobbaert CM; van der Burgt YEM; Mesker WE
J Mass Spectrom Adv Clin Lab; 2023 Jan; 27():49-55. PubMed ID: 36619217
[TBL] [Abstract][Full Text] [Related]
2. Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS).
Abbatiello SE; Mani DR; Schilling B; Maclean B; Zimmerman LJ; Feng X; Cusack MP; Sedransk N; Hall SC; Addona T; Allen S; Dodder NG; Ghosh M; Held JM; Hedrick V; Inerowicz HD; Jackson A; Keshishian H; Kim JW; Lyssand JS; Riley CP; Rudnick P; Sadowski P; Shaddox K; Smith D; Tomazela D; Wahlander A; Waldemarson S; Whitwell CA; You J; Zhang S; Kinsinger CR; Mesri M; Rodriguez H; Borchers CH; Buck C; Fisher SJ; Gibson BW; Liebler D; Maccoss M; Neubert TA; Paulovich A; Regnier F; Skates SJ; Tempst P; Wang M; Carr SA
Mol Cell Proteomics; 2013 Sep; 12(9):2623-39. PubMed ID: 23689285
[TBL] [Abstract][Full Text] [Related]
3. Method and platform standardization in MRM-based quantitative plasma proteomics.
Percy AJ; Chambers AG; Yang J; Jackson AM; Domanski D; Burkhart J; Sickmann A; Borchers CH
J Proteomics; 2013 Dec; 95():66-76. PubMed ID: 23933160
[TBL] [Abstract][Full Text] [Related]
4. Quantifying RNA modifications by mass spectrometry: a novel source of biomarkers in oncology.
Amalric A; Bastide A; Attina A; Choquet A; Vialaret J; Lehmann S; David A; Hirtz C
Crit Rev Clin Lab Sci; 2022 Jan; 59(1):1-18. PubMed ID: 34473579
[TBL] [Abstract][Full Text] [Related]
5. Protocol for the Analysis of Laser Capture Microdissected Fresh-Frozen Tissue Homogenates by Silver-Stained 1D SDS-PAGE.
Prieto DA; Whitely G; Johann DJ; Blonder J
Methods Mol Biol; 2018; 1723():95-110. PubMed ID: 29344855
[TBL] [Abstract][Full Text] [Related]
6. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
[TBL] [Abstract][Full Text] [Related]
7. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?
Kalogera E; Pistos C; Provatopoulou X; Athanaselis S; Spiliopoulou C; Gounaris A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():24-34. PubMed ID: 24140653
[TBL] [Abstract][Full Text] [Related]
8. Isotope coded protein label quantification of serum proteins--comparison with the label-free LC-MS and validation using the MRM approach.
Turtoi A; Mazzucchelli GD; De Pauw E
Talanta; 2010 Feb; 80(4):1487-95. PubMed ID: 20082806
[TBL] [Abstract][Full Text] [Related]
9. Analysis of host-cell proteins in biotherapeutic proteins by comprehensive online two-dimensional liquid chromatography/mass spectrometry.
Doneanu CE; Xenopoulos A; Fadgen K; Murphy J; Skilton SJ; Prentice H; Stapels M; Chen W
MAbs; 2012; 4(1):24-44. PubMed ID: 22327428
[TBL] [Abstract][Full Text] [Related]
10. LC-MS/MS-based targeted proteomics quantitatively detects the interaction between p53 and MDM2 in breast cancer.
Zhang W; Zhong T; Chen Y
J Proteomics; 2017 Jan; 152():172-180. PubMed ID: 27826076
[TBL] [Abstract][Full Text] [Related]
11. Targeted metabolic profiling of urinary steroids with a focus on analytical accuracy and sample stability.
Vogg N; Müller T; Floren A; Dandekar T; Scherf-Clavel O; Fassnacht M; Kroiss M; Kurlbaum M
J Mass Spectrom Adv Clin Lab; 2022 Aug; 25():44-52. PubMed ID: 35910411
[TBL] [Abstract][Full Text] [Related]
12. Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures.
Hoofnagle AN; Becker JO; Oda MN; Cavigiolio G; Mayer P; Vaisar T
Clin Chem; 2012 Apr; 58(4):777-81. PubMed ID: 22307200
[TBL] [Abstract][Full Text] [Related]
13. MRM
Korte R; Brockmeyer J
Anal Bioanal Chem; 2016 Nov; 408(27):7845-7855. PubMed ID: 27590318
[TBL] [Abstract][Full Text] [Related]
14. An investigation of heat shock protein 27 and P-glycoprotein mediated multi-drug resistance in breast cancer using liquid chromatography-tandem mass spectrometry-based targeted proteomics.
Xu F; Yang T; Fang D; Xu Q; Chen Y
J Proteomics; 2014 Aug; 108():188-97. PubMed ID: 24882106
[TBL] [Abstract][Full Text] [Related]
15. [Determination of trace
Xu X; Zhang J; Cai Z; Meng Z; Huang B; Chen Q
Se Pu; 2020 Nov; 38(11):1281-1287. PubMed ID: 34213098
[TBL] [Abstract][Full Text] [Related]
16. Strategies for large-scale targeted metabolomics quantification by liquid chromatography-mass spectrometry.
Zhou J; Yin Y
Analyst; 2016 Nov; 141(23):6362-6373. PubMed ID: 27722450
[TBL] [Abstract][Full Text] [Related]
17. Quantitative proteomic analysis of human plasma using tandem mass tags to identify novel biomarkers for herpes zoster.
Wang T; Shen H; Deng H; Pan H; He Q; Ni H; Tao J; Liu S; Xu L; Yao M
J Proteomics; 2020 Aug; 225():103879. PubMed ID: 32585426
[TBL] [Abstract][Full Text] [Related]
18. Regulatory context and validation of assays for clinical mass spectrometry proteomics (cMSP) methods.
Hirtz C; Bros P; Brede C; Lescuyer P; Maceski AM; Vialaret J; Delatour V; Lehmann S;
Crit Rev Clin Lab Sci; 2018 Aug; 55(5):346-358. PubMed ID: 29792094
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous quantification of Cyt c interactions with HSP27 and Bcl-xL using molecularly imprinted polymers (MIPs) coupled with liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based targeted proteomics.
Zhang W; Zhang T; Chen Y
J Proteomics; 2019 Feb; 192():188-195. PubMed ID: 30237093
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
